Effects of Melaleuca alternifolia (tea tree) essential oil and the major monoterpene component terpinen-4-ol on the development of single- and multistep antibiotic resistance and antimicrobial susceptibility

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 2, 2012, Pages 909-915

  Hammer, Katherine A ^a   Carson, Christine F ^a   Rileya, Thomas V ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; KANAMYCIN; TEA TREE OIL; TERPINEN 4 OL;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM MUTANT; CONTROLLED STUDY; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

CULTURE MEDIA; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; HUMANS; MELALEUCA; MICROBIAL SENSITIVITY TESTS; MONOTERPENES; SERIAL PASSAGE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TEA TREE OIL; TERPENES;

EID: 84856071718     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05741-11     Document Type: Article

References (31)

1. Ali SM, et al. 2005. Antimicrobial activities of eugenol and cinnamaldehyde against the human gastric pathogen Helicobacter pylori. Ann. Clin. Microbiol. Antimicrob. 4:20.
2. Amsterdam D. 2005. Susceptibility testing of antimicrobials in liquid media. In Lorian V (ed), Antibiotics in laboratory medicine, 5th ed. Lippincott Williams and Wilkins, Philadelphia, PA.
3. Bowler WA, Bresnahan J, Bradfish A, Fernandez C. 2010. An integrated approach to methicillin-resistant Staphylococcus aureus control in a rural, regional-referral healthcare setting. Infect. Control Hosp. Epidemiol. 31:269-275.
4. Braoudaki M, Hilton AC. 2004. Adaptive resistance to biocides in Salmonella enterica and Escherichia coli O157 and cross-resistance to antimicrobial agents. J. Clin. Microbiol. 42:73-78. (Pubitemid 38082701)
5. Carson CF, Hammer KA, Riley TV. 2006. Melaleuca alternifolia (tea tree) oil: a review of antimicrobial and other medicinal properties. Clin. Microbiol. Rev. 19:50-62. (Pubitemid 43158450)
6. Carson CF, Mee BJ, Riley TV. 2002. Mechanism of action of Melaleuca alternifolia (tea tree) oil on Staphylococcus aureus determined by time-kill, lysis, leakage, and salt tolerance assays and electron microscopy. Antimicrob. Agents Chemother. 46:1914-1920. (Pubitemid 34535215)
7. Clinical Laboratory Standards Institute. 2006. Performance standards for antimicrobial susceptibility testing, 16th informational supplement. CLSI document M100-S16. Clinical and Laboratory Standards Institute, Wayne, PA.
8. Clinical Laboratory Standards Institute. 2006. M7-A7: methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, approved standard, 7th ed. Clinical and Laboratory Standards Institute, Wayne, PA.
9. Cox SD, et al. 2000. The mode of antimicrobial action of the essential oil of Melaleuca alternifolia (tea tree oil). J. Appl. Microbiol. 88:170-175. (Pubitemid 30140195)
10. Di Pasqua R, Hoskins N, Betts G, Mauriello G. 2006. Changes in membrane fatty acids composition of microbial cells induced by addiction of thymol, carvacrol, limonene, cinnamaldehyde, and eugenol in the growing media. J. Agric. Food Chem. 54:2745-2749.
11. Dryden MS, Dailly S, Crouch M. 2004. A randomized, controlled trial of tea tree topical preparations versus a standard topical regimen for the clearance of MRSA colonization. J. Hosp. Infect. 56:283-286. (Pubitemid 38444080)
12. Evandri MG, et al. 2005. The antimutagenic activity of Lavandula angustifolia (lavender) essential oil in the bacterial reverse mutation assay. Food Chem. Toxicol. 43:1381-1387. (Pubitemid 40884613)
13. Ferrini AM, et al. 2006. Melaleuca alternifolia essential oil possesses potent anti-staphylococcal activity extended to strains resistant to antibiotics. Int. J. Immunopathol. Pharmacol. 19:539-544. (Pubitemid 44580526)
14. Fletcher JP, Cassella JP, Hughes D, Cassella S. 2005. An evaluation of the mutagenic potential of commercially available tea tree oil in the United Kingdom. Int. J. Aromather. 15:81-86. (Pubitemid 40776033)
15. Fraise AP. 2002. Biocide abuse and antimicrobial resistance-a cause for concern? J. Antimicrob. Chemother. 49:11-12. (Pubitemid 34100641)
16. Fuangthong M, et al. 2011. Exposure of Acinetobacter baylyi ADP1 to the biocide chlorhexidine leads to acquired resistance to the biocide itself and to oxidants. J. Antimicrob. Chemother. 66:319-322.
17. Gilbert P, McBain AJ. 2003. Potential impact of increased use of biocides in consumer products on prevalence of antibiotic resistance. Clin. Microbiol. Rev. 16:189-208. (Pubitemid 36519807)
18. Gustafson JE, Cox SD, Liew YC, Wyllie SG, Warmington JR. 2001. The bacterial multiple antibiotic resistant (Mar) phenotype leads to increased tolerance to tea tree oil. Pathology 33:211-215. (Pubitemid 32453416)
19. Guy ES, Mallampalli A. 2008. Managing TB in the 21st century: existing and novel drug therapies. Ther. Adv. Respir. Dis. 2:401-408.
20. International Organisation for Standardisation. 2004. ISO 4730:2004, oil of Melaleuca, terpinen-4-ol type (tea tree oil). International Organisation for Standardisation, Geneva, Switzerland.
21. Jana S, Deb JK. 2006. Molecular understanding of aminoglycoside action and resistance. Appl. Microbiol. Biotechnol. 70:140-150.
22. Kalan L, Wright GD. 2011. Antibiotic adjuvants: multicomponent anti-infective strategies. Expert Rev. Mol. Med. 13:e5.
23. McMahon M, Blair I, Moore J, McDowell D. 2007. Habituation to sub-lethal concentrations of tea tree oil (Melaleuca alternifolia) is associated with reduced susceptibility to antibiotics in human pathogens. J. Antimicrob. Chemother. 59:125-127. (Pubitemid 46017914)
24. McMahon MAS, et al. 2008. Changes in antibiotic susceptibility in staphylococci habituated to sub-lethal concentrations of tea tree oil (Melaleuca alternifolia). Lett. Appl. Microbiol. 47:263-268.
25. Mondello F, De Bernardis F, Girolamo A, Salvatore G, Cassone A. 2003. In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts. J. Antimicrob. Chemother. 51:1223-1229. (Pubitemid 36622078)
26. Papadopoulos CJ, Carson CF, Chang BJ, Riley TV. 2008. Role of the MexAB-OprM efflux pump of Pseudomonas aeruginosa in tolerance to tea tree (Melaleuca altenifolia) oil and its monoterpene components terpinen-4-ol, 1,8-cineole, and alpha-terpineol. Appl. Environ. Microbiol. 74:1932-1935. (Pubitemid 351400150)
27. Pillai S, Moellering R Jr., Eliopoulos G. 2005. Antimicrobial combinations, p. 365-440. In Lorian (ed), V. Antibiotics in laboratory medicine. Lippincott Williams & Wilkins, Philadelphia, PA.
28. Shapira R, Mimran E. 2007. Isolation and characterization of Escherichia coli mutants exhibiting altered response to thymol. Microb. Drug Resist. Mech. Epidemiol. Dis. 13:157-165. (Pubitemid 47622334)
29. Sia IG, Wieland ML. 2011. Current concepts in the management of tuberculosis. Mayo Clin. Proc. 86:348-361.
30. Thompson G, et al. 2008. A randomized controlled trial of tea tree oil (5%) body wash versus standard body wash to prevent colonization with methicillin-resistant Staphylococcus aureus (MRSA) in critically ill adults: research protocol. BMC Infect. Dis. 8:161.
31. Ultee A, Kets EPW, Alberda M, Hoekstra FA, Smid EJ. 2000. Adaptation of the food-borne pathogen Bacillus cereus to carvacrol. Arch. Microbiol. 174:233-238.